Remember, while the benefits are clear, this medication's suitability should be discussed with your healthcare provider
Some studies show that adding a GLP-1 agonist to basal insulin results in better blood sugar control with neutral weight effects, or even mild weight loss, compared to intensifying insulin alone
This kind of large, long-duration outcome study is what ultimately separates a well-understood compound from one that still carries unknowns
Tyrrell J, Mulugeta A, Wood AR, Zhou A, Beaumont RN, Tuke MA, et al
The compound class behind subscription GLP-1 plans Whatever the billing wrapper, the pharmacology is the same drug class
No afecta a su capacidad para adquirir productos, acceder a servicios o ejercer sus derechos